We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

20 hedge funds and large institutions have $6.13M invested in Alimera Sciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

43% more funds holding

Funds holding: 14 → 20 (+6)

30% less capital invested

Capital invested by funds: $8.73M → $6.13M (-$2.6M)

Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
5
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$144K
2
VCIM
Velan Capital Investment Management
Georgia
+$128K
3
Millennium Management
Millennium Management
New York
+$50.9K
4
TRCT
Tower Research Capital (TRC)
New York
+$8.46K
5
BlackRock
BlackRock
New York
+$2.37K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$43.4K
2
Morgan Stanley
Morgan Stanley
New York
-$14K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$247
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$1.81M -$14K -3,300 -0.5%
CP
2
Caligan Partners
New York
$1.3M +$2.04M +478,777 New
VCIM
3
Velan Capital Investment Management
Georgia
$699K +$128K +30,151 +13%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$678K – – –
PAI
5
Palo Alto Investors
California
$544K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$403K +$247 +58 +0%
Renaissance Technologies
7
Renaissance Technologies
New York
$278K -$43.4K -10,200 -9%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$103K -$247 -58 -0.2%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$91.5K +$144K +33,775 New
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$52K – – –
BCM
11
Bridgeway Capital Management
Texas
$49.6K – – –
PCM
12
Perritt Capital Management
Illinois
$48.8K – – –
BlackRock
13
BlackRock
New York
$36.4K +$2.37K +557 +4%
Millennium Management
14
Millennium Management
New York
$32K +$50.9K +11,963 New
TRCT
15
Tower Research Capital (TRC)
New York
$11K +$8.46K +1,987 +100%
JP Morgan Chase
16
JP Morgan Chase
New York
$1K +$2.24K +526 New
FWM
17
Focused Wealth Management
New York
$179 – – –
MCC
18
Money Concepts Capital
Florida
$163 +$255 +60 New
Wells Fargo
19
Wells Fargo
California
$103 +$4 +1 +3%
Bank of America
20
Bank of America
North Carolina
$16 +$26 +6 New

ALIM Hedge Fund Activity: Q4 2022 in Review

20 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2022, worth a combined $6.13M — down 30% from $8.73M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ALIM positions and 0 closed out — a net gain of 6 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $144K. The largest seller was Renaissance Technologies, cutting an estimated $43.4K.

  • 20 institutional investors held Alimera Sciences (ALIM) as of Q4 2022, up from 14 in Q3 2022.
  • Funds reported $6.13M of Alimera Sciences stock for Q4 2022, down 30% quarter-over-quarter.
  • 6 funds opened new Alimera Sciences positions in Q4 2022 and 0 closed out, a net change of +6 holders.
  • The largest Alimera Sciences buyer in Q4 2022 was Susquehanna International Group, an estimated $144K added.
  • The largest Alimera Sciences seller in Q4 2022 was Renaissance Technologies, an estimated $43.4K sold.

Based on aggregated 13F filings for Q4 2022.